AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology ...
As organizations scale AI, many are discovering that the biggest obstacles are not technical. They are rooted in process ...
This removes the need for complex reconstruction algorithms typically required in tactile sensing. The technology could ...